Strikingly, YAP1 overexpression was much higher in the soft tissue neoplasms, suggesting activation of the Hippo pathway in these tumors, as YAP is the effector of the Hippo pathway in association with TAZ/TEAD transcription factors [40]. The gene discussed is YAP1; the disease is soft tissue neoplasm.